Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors.
Key PointsChief Medical Officer Helen Collins sold 5,000 shares of Common Stock for a total of ~$199,000 on May 18, 2026, at an average price of around $39.79 per share.
Quelle est votre réaction ?
Aimer
0
Je n'aime pas
0
Amour
0
Drôle
0
En colère
0
Triste
0
Waouh
0
